| Effect of elastase on primary graft patency after femoralpopliteal arterial bypass for arteriosclerosis obliterans: a randomized, controlled study. | |
| | |
MedLine Citation:
|
PMID: 9189814 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
METHODS: Studies were carried out on 104 limbs with femoralpopliteal bypasses for arteriosclerosis obliterans (ASO). They were randomized to a group receiving elastase (10800 EL. U. P.O. per day) with an antiplatelet drug (Elastase group, 58 patients) or a group receiving only the antiplatelet drug (Control group, 46 patients). The follow-up period ranged from 24 to 36 months after operation at 22 institutions across Japan. RESULTS: The cumulative graft patency rate was higher in the Elastase group than the Control group, but the difference lacked statistical significance. When autogenous saphenous veins were used, the cumulative graft patency rate was significantly higher in the Elastase group than the Control group. CONCLUSIONS: The present study suggests that elastase is effective in maintaining graft patency in femoralpopliteal arterial bypass when an autogenous saphenous vein is used as a graft. |
| | |
Authors:
|
K Fujioka; K Esato; N Zempo |
Related Documents
:
|
3518514 - Extraperitoneal approach for aortoiliac reconstruction of the abdominal aorta. 20106404 - Late-term results of tissue-engineered vascular grafts in humans. 23010744 - Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for en... 23620574 - Early responses predicts for better outcomes in patients with newly diagnosed cml: resu... 19542094 - Reward contrast in delay and probability discounting. 22243484 - Long-term effectiveness and safety of small-gel-particle hyaluronic acid for hand rejuv... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: International surgery Volume: 82 ISSN: 0020-8868 ISO Abbreviation: Int Surg Publication Date: 1997 Jan-Mar |
Date Detail:
|
Created Date: 1997-07-17 Completed Date: 1997-07-17 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0043524 Medline TA: Int Surg Country: ITALY |
Other Details:
|
Languages: eng Pagination: 94-7 Citation Subset: IM |
Affiliation:
|
First Department of Surgery, Yamaguchi University School of Medicine, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Arteriosclerosis Obliterans / physiopathology, surgery* Blood Vessel Prosthesis Drug Therapy, Combination Female Femoral Artery / surgery* Humans Male Middle Aged Pancreatic Elastase / therapeutic use* Platelet Aggregation Inhibitors / therapeutic use* Popliteal Artery / surgery* Saphenous Vein / transplantation Transplantation, Autologous Vascular Patency / drug effects* Vascular Surgical Procedures / methods |
| Chemical | |
Reg. No./Substance:
|
0/Platelet Aggregation Inhibitors; EC 3.4.21.36/Pancreatic Elastase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effectiveness of hyperthermia and radiation treatments for patients with esophageal cancer predicted...
Next Document: Pyogenic liver abscess: the role of surgical treatment.